Despite not identifying any impact of high or low expression of IL-17 in GBM tumors on overall survival probability in our study, the strong negative association between the level of IL-17 gene expression and progression free survival probability was found (Supplementary Figure S5). Here, IL17A is linked to glioblastoma.